BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder | MicrobiomeTrials← Back to trialsNCT07872878
BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11Est. Completion: 2030-12
Enrollment target: 60 participants Locations- University Hospital of Angers, Angers, France
- Hospital of Laval, Laval, France
- Centre de Santé Mentale Angevin, Sainte-Gemmes-sur-Loire, France
Other microbiome trials you might be interested in
Bipolar I Disorder
At present, the treatment of Bipolar I disorder (BD-I), especially its depressive episode (bipolar depression), is still…
Taichung, TaiwanEst. completion Nov 2027
Schizophrenia DisorderSchizoaffective DisorderBipolar Disorder (BD)Substance Use Disorder (SUD)
This study is a randomized controlled trial evaluating the impact of financial incentives on medication adherence among …
McKeesport, United StatesCompleted Mar 2029
Bipolar Disorder (BD)Major Depressive Diorder
The goal of this clinical trial is to learn if the real-time bio-signal monitoring device (Neuronicle FX2 device), combi…
Seoul, South KoreaCompleted Jun 11, 2026